Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma
Completed
- Conditions
- Duodenal Cancer
- Registration Number
- NCT05134961
- Lead Sponsor
- Bispebjerg Hospital
- Brief Summary
The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 113
Inclusion Criteria
- Patients subjected to resection of primary duodenal adenocarcinoma
Exclusion Criteria
- None.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year survival Three years Cumulative survival after three years
- Secondary Outcome Measures
Name Time Method Duodenal cancer recurrence 5 years Recurrence found by computed tomography scan
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms are associated with long-term survival after curative resection of primary duodenal adenocarcinoma?
How does surgical resection of primary duodenal adenocarcinoma compare to other treatment modalities in terms of long-term outcomes?
Are there specific biomarkers that correlate with improved prognosis in patients undergoing resection for duodenal cancer?
What are the potential adverse events following curative resection of duodenal adenocarcinoma and how are they managed?
What combination therapies or targeted agents are being explored for duodenal cancer in relation to resection outcomes?
Trial Locations
- Locations (1)
Kristian Schaumburg Kiim
🇩🇰Copenhagen NV, Copenhagen, Denmark
Kristian Schaumburg Kiim🇩🇰Copenhagen NV, Copenhagen, Denmark